These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22458506)
21. Peptidomimetic inhibitors of cathepsin K. Black WC Curr Top Med Chem; 2010; 10(7):745-51. PubMed ID: 20337585 [TBL] [Abstract][Full Text] [Related]
22. Cruzain : the path from target validation to the clinic. Sajid M; Robertson SA; Brinen LS; McKerrow JH Adv Exp Med Biol; 2011; 712():100-15. PubMed ID: 21660661 [TBL] [Abstract][Full Text] [Related]
23. Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. Cianni L; Lemke C; Gilberg E; Feldmann C; Rosini F; Rocho FDR; Ribeiro JFR; Tezuka DY; Lopes CD; de Albuquerque S; Bajorath J; Laufer S; Leitão A; Gütschow M; Montanari CA PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007755. PubMed ID: 32163418 [TBL] [Abstract][Full Text] [Related]
24. Cysteine peptidase inhibitors in trypanosomatid parasites. Lima AP; Reis FC; Costa TF Curr Med Chem; 2013; 20(25):3152-73. PubMed ID: 23514421 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors. Steverding D Exp Parasitol; 2015; 151-152():28-33. PubMed ID: 25662707 [TBL] [Abstract][Full Text] [Related]
26. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria. Di Chio C; Starvaggi J; Totaro N; Previti S; Natale B; Cosconati S; Bogacz M; Schirmeister T; Legac J; Rosenthal PJ; Zappalà M; Ettari R Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673995 [TBL] [Abstract][Full Text] [Related]
27. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease. Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867 [TBL] [Abstract][Full Text] [Related]
29. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain. McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866 [TBL] [Abstract][Full Text] [Related]
30. Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases. Li L; Chenna BC; Yang KS; Cole TR; Goodall ZT; Giardini M; Moghadamchargari Z; Hernandez EA; Gomez J; Calvet CM; Bernatchez JA; Mellott DM; Zhu J; Rademacher A; Thomas D; Blankenship LR; Drelich A; Laganowsky A; Tseng CK; Liu WR; Wand AJ; Cruz-Reyes J; Siqueira-Neto JL; Meek TD J Med Chem; 2021 Aug; 64(15):11267-11287. PubMed ID: 34288674 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873 [TBL] [Abstract][Full Text] [Related]
32. Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease. Beaulieu C; Isabel E; Fortier A; Massé F; Mellon C; Méthot N; Ndao M; Nicoll-Griffith D; Lee D; Park H; Black WC Bioorg Med Chem Lett; 2010 Dec; 20(24):7444-9. PubMed ID: 21041084 [TBL] [Abstract][Full Text] [Related]
33. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense. Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806 [TBL] [Abstract][Full Text] [Related]
34. Improved trypanocidal activities of cathepsin L inhibitors. Nkemgu NJ; Grande R; Hansell E; McKerrow JH; Caffrey CR; Steverding D Int J Antimicrob Agents; 2003 Aug; 22(2):155-9. PubMed ID: 12927956 [TBL] [Abstract][Full Text] [Related]
35. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Doyle PS; Zhou YM; Engel JC; McKerrow JH Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625 [TBL] [Abstract][Full Text] [Related]